Hyperlipidaemia and venous thromboembolism in patients lacking thrombophilic risk factors
Authors:
Open Access
- 3 July 2002
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 118 (1) , 255-259
Abstract
Summary. To ascertain the potential contribution of serum lipids to the development of deep vein thrombosis (DVT), a case–control study was conducted in 143 DVT patients lacking thrombophilic risk factors and in 194 age‐ and sex‐matched controls. DVT patients showed significantly higher body mass indices (BMI), and triglyceride levels than did controls (P < 0·001 and P = 0·045 respectively). Using multivariate analysis, BMI was the only variable which remained statistically different, thus the risk of DVT was associated with obesity (odds ratio = 2·49). These results were confirmed when additional control for fibrinogen and plasminogen activator inhibitor type 1 (PAI‐1) was carried out in a subgroup of cases and controls. When idiopathic (n = 39) and secondary (n = 104) patients with DVT were compared, the former showed a higher mean age, a higher proportion of men, and higher cholesterol levels. Age, sex and total cholesterol were statistically different by multivariate analysis. After age was dichotomized as ≥ 50 years and cholesterol ≥ 5·69 mmol/l, all three variables constituted independent risk factors for idiopathic DVT, with odds ratios of 2·73 for ages ≥ 50 years; 3·72 for men and 2·67 for cholesterolaemia ≥ 5·69 mmol/l. Obesity thus constitutes an independent risk factor for DVT, possibly in part mediated through triglyceride, fibrinogen and PAI‐1 effects on haemostasis. In addition, cholesterolaemia levels of ≥ 5·69 mmol/l constitute an independent risk factor for idiopathic DVT.Keywords
This publication has 27 references indexed in Scilit:
- PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defectsBritish Journal of Haematology, 2000
- PAI‐1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defectsBritish Journal of Haematology, 2000
- Impaired Anticoagulant Response to Infusion of Thrombin in Atherosclerotic Monkeys Associated With Acquired Defects in the Protein C SystemArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- PAI-1 Plasma Levels in a General Population Without Clinical Evidence of AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogensThe Lancet, 1996
- Tissue Factor Pathway Inhibitor Activity in Human PlasmaArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Acquired risk factors for deep-vein thrombosis in symptomatic outpatientsArchives of internal medicine (1960), 1994
- Red blood cell aggregation and primary hyperlipoproteinemiaThrombosis Research, 1993
- Regulation of Endothelial Cell Protein C Activation by Native and Oxidized Low Density LipoproteinSeminars in Thrombosis and Hemostasis, 1992
- A1, A2, B, AND O BLOOD-GROUPS, LEWIS BLOOD-GROUPS, AND SERUM TRIGLYCERIDE AND CHOLESTEROL CONCENTRATIONS IN PATIENTS WITH VENOUS THROMBOEMBOLIC DISEASEThe Lancet, 1972